已发表论文

近期针对单核细胞增生李斯特菌感染的宿主免疫机制研究进展

 

Authors Shang L, Xiang W , Lun M, Qu S , Yin Y , Xu Y , Zhou Y, Zhu P, Song Y 

Received 15 May 2025

Accepted for publication 25 July 2025

Published 11 August 2025 Volume 2025:18 Pages 10821—10833

DOI https://doi.org/10.2147/JIR.S535302

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Editor who approved publication: Prof. Dr. Dharmappa Krishnappa

Lanqi Shang,1– 3 Weijia Xiang,1– 3 Mengting Lun,1– 3 Songyan Qu,1– 3 Yizhen Yin,1– 3 Ya Xu,1– 3 Yongqin Zhou,1– 3 Ping Zhu,4 Yinhong Song1– 3 

1Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People’s Republic of China; 2Institution of Infection and Inflammation, China Three Gorges University, Yichang, People’s Republic of China; 3College of Basic Medical Sciences, China Three Gorges University, Yichang, People’s Republic of China; 4Department of Nephrology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, People’s Republic of China

Correspondence: Yinhong Song, Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, People’s Republic of China, Email syh728@ctgu.edu.cn Ping Zhu, Department of Nephrology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, People’s Republic of China, Email topgan2000@163.com

Abstract: Listeria monocytogenes (Lm) is a foodborne Gram-positive pathogenic bacterium that primarily causes clinical manifestations such as sepsis, meningitis, and monocytosis. The main susceptible populations include newborns, pregnant women, adults over 40 years old, and immunocompromised individuals. Currently, antibiotic therapy remains the primary clinical treatment, but in recent years the issue of antibiotic resistance has become increasingly prominent. This review summarizes recent advances in host immune mechanisms against Lm infection, focusing on: (1) the defensive roles of host barrier systems (intestinal, blood-brain, and placental barriers); (2) innate immune responses, including pathogen recognition via TLRs/NLRs signaling pathways, macrophage phagocytosis, and NK cell immune surveillance; and (3) adaptive immunity, particularly CD4+/CD8+ T cell-mediated specific immune responses and the long-term protective effects of memory T cells. By systematically elucidating the molecular mechanisms of these immune processes, this review aims to provide novel therapeutic strategies through enhancement of host immune functions for clinical management of Lm infection.

Keywords: listeria monocytogenes, infection, host, immunity